Catalent inks a $619M deal to help Roche develop targeted therapie
Catalent's Mike Riley
Catalent Pharma Solutions ($CTLT) is loaning out one of its drug development platforms to Roche ($RHHBY) in a heavily back-loaded dea...
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.